Fluxion Biosciences Signs New Distributor for Benelux and Scandinavia; Westburg BV to Distribute BioFlux Line of Live Cell Imaging Products

San Francisco, Calif. (December 2, 2008) - Fluxion Biosciences announced today an exclusive distribution agreement with The Netherlands-based Westburg BV. Westburg BV will handle sales and service of Fluxion's BioFlux research tools for live cell image analysis in Belgium, The Netherlands, Luxembourg, Denmark, Finland, Iceland, Norway and Sweden.

For more than 20 years Westburg BV has been a distributor of innovative, high-quality products for genomics, protein research, cell biology and molecular diagnostics in Benelux and the Nordic countries. With its team of trained experts, Westburg provides functional solutions supported by technical, experimental and scientific assistance.

"We selected Westburg because of their extensive experience and contacts in Benelux and Scandinavia," explained Mark Atlas, director of sales for Fluxion. "The relationship will complement Westburg's product portfolio and give us access to their cell biology customers."

"The cooperation of Fluxion Biosciences and Westburg will both expand and strengthen our position in the blooming fields of cell physiology, pharmacology and stem cell research by providing an innovative and comprehensive research tool for our customers," said Eppo Boneschanscher, CEO of Westburg. "We are happy to add Fluxion to the list of companies that make Westburg their partner of choice."

The Fluxion BioFlux 200 system is ideal for live cell imaging in applications such as cell adhesion and microbial biofilm studies. BioFlux 200 incorporates Fluxion's proprietary microfluidic design to deliver an automated, reproducible system for studying live cells and biofilms under controlled-shear conditions. The system simulates in vivo physiological conditions more closely and at higher throughput than other approaches.

About Fluxion Biosciences

Fluxion Biosciences provides cellular analysis tools for use in critical life science research and drug discovery applications. Fluxion's proprietary microfluidic platform enables precise functional analysis of individual cells in a multiplexed format. Fluxion's systems meet the rigorous demands of life science and drug discovery scientists by providing an intuitive, easy-to-use operating system for single-cell biology. For more information about Fluxion Biosciences, visit www.fluxionbio.com.

Back to news